Prospera Financial Services Inc Moderna, Inc. Transaction History

Prospera Financial Services Inc

$3.82 Billion
Q3 2024

A detailed history of Prospera Financial Services Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Prospera Financial Services Inc holds 3,083 shares of MRNA stock, worth $113,608. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,083

Previous 16,756 81.6%

Holding current value

$113,608

Previous $1.99 Million 89.64%

% of portfolio

0.01%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$63.64 - $125.14 $870,149 - $1.71 Million	-13,673 Reduced 81.6%	3,083 $206,000
Q2 2024 Aug 13, 2024	BUY	$101.21 - $166.61 $1.33 Million - $2.19 Million	13,121 Added 360.96%	16,756 $1.99 Million
Q1 2024 Aug 13, 2024	SELL	$85.37 - $115.44 $1.12 Million - $1.51 Million	-13,093 Reduced 78.14%	3,663 $390,000
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $57,623 - $86,572	-829 Reduced 18.57%	3,635 $361,000
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $74,910 - $98,375	-777 Reduced 14.83%	4,464 $461,000
Q2 2023 Aug 08, 2023	SELL	$118.5 - $160.53 $102,265 - $138,537	-863 Reduced 14.14%	5,241 $636,000
Q1 2023 May 12, 2023	SELL	$135.66 - $197.02 $1.02 Million - $1.48 Million	-7,509 Reduced 55.16%	6,104 $937,000
Q4 2022 Feb 08, 2023	BUY	$118.38 - $210.04 $972,373 - $1.73 Million	8,214 Added 152.14%	13,613 $2.45 Million
Q3 2022 Oct 27, 2022	BUY	$118.07 - $194.18 $367,551 - $604,482	3,113 Added 136.18%	5,399 $639,000
Q2 2022 Aug 08, 2022	SELL	$117.13 - $176.59 $61,258 - $92,356	-523 Reduced 18.62%	2,286 $327,000
Q1 2022 May 04, 2022	BUY	$126.46 - $235.05 $13,404 - $24,915	106 Added 3.92%	2,809 $484,000
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $729,398 - $1.19 Million	-3,230 Reduced 54.44%	2,703 $687,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $85,209 - $186,036	384 Added 6.92%	5,933 $2.28 Million
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $185,251 - $335,081	1,426 Added 34.59%	5,549 $1.3 Million
Q1 2021 May 06, 2021	BUY	$109.18 - $185.98 $15,831 - $26,967	145 Added 3.65%	4,123 $539,000
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $250,009 - $645,977	3,803 Added 2173.14%	3,978 $415,000
Q3 2020 Nov 04, 2020	BUY	$54.34 - $94.85 $9,509 - $16,598	175 New	175 $12,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Account

Prospera Financial Services Inc Moderna, Inc. Transaction History